Numerous genome wide association studies (GWAS) linking GPR65 polymorphism to increased incidence of inflammatory bowel disease (IBD) and other autoimmune/autoinflammatory diseases (26–30) highlight the importance of GPR65’s regulatory functions on the immune system. This evidence concerns the gene GPR65 and inflammatory bowel disease.